06/07/2024 3:44 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024 4:31 PM | Jazz Pharmaceuticals (Issuer) Patil Neena M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 6:38 AM | Jazz Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/09/2024 3:39 PM | GALA RENEE D (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 5:07 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 8:49 PM | Jazz Pharmaceuticals (Issuer) Pearce Samantha (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 8:53 PM | GALA RENEE D (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/07/2024 8:44 PM | COZADD BRUCE C (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 8:47 PM | Iannone Robert (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 8:48 PM | Jazz Pharmaceuticals (Issuer) Patil Neena M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 5:09 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 6:54 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:58 PM | Henderson Mary Elizabeth (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:28 PM | Jazz Pharmaceuticals (Issuer) Johnson Philip L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:32 PM | Jazz Pharmaceuticals (Issuer) Kennedy Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:34 PM | COZADD BRUCE C (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:44 PM | GALA RENEE D (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:47 PM | Iannone Robert (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:50 PM | Jazz Pharmaceuticals (Issuer) Patil Neena M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:52 PM | Jazz Pharmaceuticals (Issuer) Pearce Samantha (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 6:11 PM | Jazz Pharmaceuticals (Issuer) Kennedy Patrick (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/05/2024 6:14 PM | Jazz Pharmaceuticals (Issuer) Johnson Philip L (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/01/2024 2:11 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024 3:06 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/27/2024 6:45 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/21/2024 6:46 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2024 6:29 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
01/25/2024 4:01 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/24/2024 8:46 AM | BlackRock Inc. (Filed by) Jazz Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/19/2024 5:19 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 5:21 PM | COZADD BRUCE C (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 5:23 PM | GALA RENEE D (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 5:25 PM | Iannone Robert (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 5:28 PM | Jazz Pharmaceuticals (Issuer) Patil Neena M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 5:33 PM | Jazz Pharmaceuticals (Issuer) Pearce Samantha (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 6:45 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/15/2023 6:45 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/06/2023 3:39 PM | Jazz Pharmaceuticals (Issuer) Smith Mark Douglas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2023 3:31 PM | Cook Jennifer E. (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2023 6:36 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2023 12:33 PM | Jazz Pharmaceuticals (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
Top 5 Tech Stocks to Buy for 2024 (Ad) The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world's most powerful tech companies (including Microsoft, Intel, and Google) investing billions. And one tiny company will be the driving force behind this new tech revolution… Click below for your free report "Top 5 Tech Stocks to Buy in 2024", |
09/06/2023 4:09 PM | Jazz Pharmaceuticals (Issuer) Patil Neena M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/01/2023 3:39 PM | Jazz Pharmaceuticals (Subject) Patil Neena M (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/31/2023 5:44 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/29/2023 4:41 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/17/2023 4:21 PM | Jazz Pharmaceuticals (Issuer) Patil Neena M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 6:49 PM | Jazz Pharmaceuticals (Issuer) O'Keefe Kenneth W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 6:51 PM | Jazz Pharmaceuticals (Issuer) ORiordan Anne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 4:58 PM | Jazz Pharmaceuticals (Issuer) RIEDEL NORBERT G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 5:00 PM | Jazz Pharmaceuticals (Issuer) Smith Mark Douglas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 5:02 PM | Jazz Pharmaceuticals (Issuer) Sohn Catherine A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 5:08 PM | Jazz Pharmaceuticals (Issuer) Winningham Rick E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 4:47 PM | Gray Peter (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 4:49 PM | Henderson Mary Elizabeth (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 4:52 PM | Jazz Pharmaceuticals (Issuer) McSharry Heather Ann (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 4:56 PM | Jazz Pharmaceuticals (Issuer) Mulligan Seamus (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 4:40 PM | Jazz Pharmaceuticals (Subject) Patil Neena M (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023 4:43 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 4:44 PM | Cook Jennifer E. (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 4:45 PM | ENRIGHT PATRICK G (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2023 8:55 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 8:35 PM | Jazz Pharmaceuticals (Subject) Winningham Rick E (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 8:40 PM | Gray Peter (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 8:28 PM | ENRIGHT PATRICK G (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 8:00 PM | Jazz Pharmaceuticals (Subject) McSharry Heather Ann (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 8:04 PM | Cook Jennifer E. (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 8:09 PM | Jazz Pharmaceuticals (Subject) O'Keefe Kenneth W (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 8:15 PM | Jazz Pharmaceuticals (Subject) Smith Mark Douglas (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 8:19 PM | Jazz Pharmaceuticals (Subject) RIEDEL NORBERT G (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 7:54 PM | Jazz Pharmaceuticals (Subject) Sohn Catherine A. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 7:36 PM | Jazz Pharmaceuticals (Subject) ORiordan Anne (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 5:41 PM | Henderson Mary Elizabeth (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
06/22/2023 3:05 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/16/2023 3:12 PM | Jazz Pharmaceuticals (Filer)
| Form DEF 14A | |
06/12/2023 3:47 PM | Jazz Pharmaceuticals (Issuer) Mulligan Seamus (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |